Atom | Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Funder: National Institutes of Health

Funding Amounts: Up to $450,000 direct costs over 3 years; no more than $225,000 in direct costs in any single year.

Summary: Supports formative research, development, and pilot-testing of novel or adapted interventions to improve HIV prevention, treatment, or service implementation for people who use substances, requiring a clinical trial.

Key Information: Clinical trial is required; strong end-user engagement and a theory of change or logic model must be included.

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Sign in to see full grant listing